| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Active surveillance preferred for low-risk prostate cancer
|
Bagcchi, Sanjeet
|
|
2015
|
16 |
8 |
p. e384-
1 p.
|
artikel
|
| 2 |
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial
|
Soria, Jean-Charles
|
|
2015
|
16 |
8 |
p. 897-907
11 p.
|
artikel
|
| 3 |
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial
|
Tabernero, Josep
|
|
2015
|
16 |
8 |
p. 937-948
12 p.
|
artikel
|
| 4 |
Barriers to overcome for effective cancer control in Africa
|
Harford, Joe B
|
|
2015
|
16 |
8 |
p. e385-e393
nvt p.
|
artikel
|
| 5 |
Bevacizumab in newly diagnosed ovarian cancer
|
Liu, Joyce F
|
|
2015
|
16 |
8 |
p. 876-878
3 p.
|
artikel
|
| 6 |
Bollywood's cancer: disconnect between reel and real oncology
|
Pati, Sanghamitra
|
|
2015
|
16 |
8 |
p. 894-895
2 p.
|
artikel
|
| 7 |
Breast cancer risk in women with PALB2 mutations in different populations
|
Antoniou, Antonis C
|
|
2015
|
16 |
8 |
p. e375-e376
nvt p.
|
artikel
|
| 8 |
Capacity building for oncology programmes in sub-Saharan Africa: the Rwanda experience
|
Stulac, Sara
|
|
2015
|
16 |
8 |
p. e405-e413
nvt p.
|
artikel
|
| 9 |
Carcinogenicity of lindane, DDT, and 2,4-dichlorophenoxyacetic acid
|
Loomis, Dana
|
|
2015
|
16 |
8 |
p. 891-892
2 p.
|
artikel
|
| 10 |
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
|
Valle, Juan W
|
|
2015
|
16 |
8 |
p. 967-978
12 p.
|
artikel
|
| 11 |
Chemotherapy and antiangiogenics in biliary tract cancer
|
Goyal, Lipika
|
|
2015
|
16 |
8 |
p. 882-883
2 p.
|
artikel
|
| 12 |
Circulating DNA biomarkers: a primer for metastatic colorectal cancer?
|
Eng, Cathy
|
|
2015
|
16 |
8 |
p. 878-879
2 p.
|
artikel
|
| 13 |
Correction to Lancet Oncol 2011; 12: 625
|
|
|
2015
|
16 |
8 |
p. e379-
1 p.
|
artikel
|
| 14 |
Corruption in health-care systems and its effect on cancer care in Africa
|
Mostert, Saskia
|
|
2015
|
16 |
8 |
p. e394-e404
nvt p.
|
artikel
|
| 15 |
CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study
|
Cassier, Philippe A
|
|
2015
|
16 |
8 |
p. 949-956
8 p.
|
artikel
|
| 16 |
Disparities in end-of-life care
|
Burki, Talha Khan
|
|
2015
|
16 |
8 |
p. e383-
1 p.
|
artikel
|
| 17 |
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial
|
Garcia-Aguilar, Julio
|
|
2015
|
16 |
8 |
p. 957-966
10 p.
|
artikel
|
| 18 |
EGFR tyrosine kinase inhibitors in squamous cell lung cancer
|
Hirsch, Fred R
|
|
2015
|
16 |
8 |
p. 872-873
2 p.
|
artikel
|
| 19 |
Establishment of a cancer surveillance programme: the South African experience
|
Singh, Elvira
|
|
2015
|
16 |
8 |
p. e414-e421
nvt p.
|
artikel
|
| 20 |
Excessive imaging for breast cancer in Ontario
|
Burki, Talha Khan
|
|
2015
|
16 |
8 |
p. e381-
1 p.
|
artikel
|
| 21 |
Extending neoadjuvant chemotherapy in rectal cancer
|
Roselló, Susana
|
|
2015
|
16 |
8 |
p. 880-881
2 p.
|
artikel
|
| 22 |
Fighting tumour with humour
|
Brierley, Bente Brattland
|
|
2015
|
16 |
8 |
p. 895-896
2 p.
|
artikel
|
| 23 |
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial
|
Soria, Jean-Charles
|
|
2015
|
16 |
8 |
p. 990-998
9 p.
|
artikel
|
| 24 |
High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study
|
Appelt, Ane L
|
|
2015
|
16 |
8 |
p. 919-927
9 p.
|
artikel
|
| 25 |
Is it time for watchful waiting for rectal cancer?
|
Breugom, Anne J
|
|
2015
|
16 |
8 |
p. 875-876
2 p.
|
artikel
|
| 26 |
Is the benefit of oxaliplatin in rectal cancer clinically relevant?
|
Glimelius, Bengt
|
|
2015
|
16 |
8 |
p. 883-885
3 p.
|
artikel
|
| 27 |
Love in a time of cancer
|
Morgan, Jules
|
|
2015
|
16 |
8 |
p. 896-
1 p.
|
artikel
|
| 28 |
Maintaining drug supply to Greece in an uncertain future
|
Burki, Talha Khan
|
|
2015
|
16 |
8 |
p. e382-
1 p.
|
artikel
|
| 29 |
Medopad
|
Xanthos, Dimitris
|
|
2015
|
16 |
8 |
p. 893-
1 p.
|
artikel
|
| 30 |
NICE guideline focuses on symptoms to diagnose cancer earlier
|
Mayor, Susan
|
|
2015
|
16 |
8 |
p. 889-
1 p.
|
artikel
|
| 31 |
N-of-1 trials in oncology
|
Collette, Laurence
|
|
2015
|
16 |
8 |
p. 885-886
2 p.
|
artikel
|
| 32 |
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
|
Rödel, Claus
|
|
2015
|
16 |
8 |
p. 979-989
11 p.
|
artikel
|
| 33 |
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|
Ribas, Antoni
|
|
2015
|
16 |
8 |
p. 908-918
11 p.
|
artikel
|
| 34 |
Prenatal testing can detect occult cancer in pregnant women
|
Tanday, Sanjay
|
|
2015
|
16 |
8 |
p. e383-
1 p.
|
artikel
|
| 35 |
Relapse models for clear cell renal carcinoma
|
Gulati, Sakshi
|
|
2015
|
16 |
8 |
p. e376-e378
nvt p.
|
artikel
|
| 36 |
Relapse models for clear cell renal carcinoma – Authors' reply
|
Rini, Brian
|
|
2015
|
16 |
8 |
p. e378-
1 p.
|
artikel
|
| 37 |
Restoring confidence in research integrity
|
The Lancet Oncology,
|
|
2015
|
16 |
8 |
p. 871-
1 p.
|
artikel
|
| 38 |
Rosacea associated with increased risk of some cancers
|
Bagcchi, Sanjeet
|
|
2015
|
16 |
8 |
p. e382-
1 p.
|
artikel
|
| 39 |
Routine screening with CT not justified for occult cancer
|
Bagcchi, Sanjeet
|
|
2015
|
16 |
8 |
p. e381-
1 p.
|
artikel
|
| 40 |
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
|
Oza, Amit M
|
|
2015
|
16 |
8 |
p. 928-936
9 p.
|
artikel
|
| 41 |
Strengthening the oncology nurse workforce in low-income and middle-income countries
|
Galassi, Annette
|
|
2015
|
16 |
8 |
p. 887-888
2 p.
|
artikel
|
| 42 |
Surgery versus SABR for resectable non-small-cell lung cancer
|
Hamaji, Masatsugu
|
|
2015
|
16 |
8 |
p. e372-
1 p.
|
artikel
|
| 43 |
Surgery versus SABR for resectable non-small-cell lung cancer
|
Dearman, Charles
|
|
2015
|
16 |
8 |
p. e373-e374
nvt p.
|
artikel
|
| 44 |
Surgery versus SABR for resectable non-small-cell lung cancer
|
Cao, Christopher
|
|
2015
|
16 |
8 |
p. e370-e371
nvt p.
|
artikel
|
| 45 |
Surgery versus SABR for resectable non-small-cell lung cancer
|
Opitz, Isabelle
|
|
2015
|
16 |
8 |
p. e372-e373
nvt p.
|
artikel
|
| 46 |
Surgery versus SABR for resectable non-small-cell lung cancer
|
Zhang, Lei
|
|
2015
|
16 |
8 |
p. e371-e372
nvt p.
|
artikel
|
| 47 |
Surgery versus SABR for resectable non-small-cell lung cancer – Authors' reply
|
Chang, Joe Y
|
|
2015
|
16 |
8 |
p. e374-e375
nvt p.
|
artikel
|
| 48 |
Sweet Life
|
Lozano-Wilhelmi, Marta
|
|
2015
|
16 |
8 |
p. 893-894
2 p.
|
artikel
|
| 49 |
The growing problem of benign connective tissue tumours
|
Thomas, David M
|
|
2015
|
16 |
8 |
p. 879-880
2 p.
|
artikel
|
| 50 |
The perceptions of a surgical cure
|
Gunjur, Ashray
|
|
2015
|
16 |
8 |
p. e380-
1 p.
|
artikel
|
| 51 |
The place of PD-1 inhibitors in melanoma management
|
Bowyer, Samantha
|
|
2015
|
16 |
8 |
p. 873-874
2 p.
|
artikel
|
| 52 |
17th World Congress on Gastrointestinal Cancers
|
Brierley, Rob
|
|
2015
|
16 |
8 |
p. 890-
1 p.
|
artikel
|
| 53 |
Tubal ligation could reduce mortality in endometrial cancer
|
Gruber, Karl
|
|
2015
|
16 |
8 |
p. e380-
1 p.
|
artikel
|
| 54 |
US states shun HPV vaccination
|
Tanday, Sanjay
|
|
2015
|
16 |
8 |
p. e384-
1 p.
|
artikel
|
Tijdschrift beschrijving